Literature DB >> 20498629

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression.

Z Chen1, Y Li, H Zhang, P Huang, R Luthra.   

Abstract

The mechanisms of compromised mitochondrial function under various pathological conditions, including hypoxia, remain largely unknown. Recent studies have shown that microRNA-210 (miR-210) is induced by hypoxia under the regulation of hypoxia-inducible factor-1alpha and has an important role in cell survival under hypoxic microenvironment. Hence, we hypothesized that miR-210 has a role in regulating mitochondrial metabolism and investigated miR-210 effects on mitochondrial function in cancer cell lines under normal and hypoxic conditions. Our results demonstrate that miR-210 decreases mitochondrial function and upregulates the glycolysis, thus make cancer cells more sensitive to glycolysis inhibitor. miR-210 can also activate the generation of reactive oxygen species (ROS). ISCU (iron-sulfur cluster scaffold homolog) and COX10 (cytochrome c oxidase assembly protein), two important factors of the mitochondria electron transport chain and the tricarboxylic acid cycle have been identified as potential targets of miR-210. The unique means by which miR-210 regulates mitochondrial function reveals an miRNA-mediated link between microenvironmental stress, oxidative phosphorylation, ROS and iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498629     DOI: 10.1038/onc.2010.193

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  165 in total

Review 1.  Redox regulation of mitochondrial function.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-02-03       Impact factor: 8.401

2.  A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts.

Authors:  R Faraonio; P Salerno; F Passaro; C Sedia; A Iaccio; R Bellelli; T C Nappi; M Comegna; S Romano; G Salvatore; M Santoro; F Cimino
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 3.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

Review 4.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 5.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

Review 6.  Invited review: decoding the microRNA response to hypoxia.

Authors:  Roger Pocock
Journal:  Pflugers Arch       Date:  2011-01-05       Impact factor: 3.657

Review 7.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 8.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

Review 9.  Mitochondrial epigenetics in bone remodeling during hyperhomocysteinemia.

Authors:  Anuradha Kalani; Pradip K Kamat; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

10.  MIR-210 modulates mitochondrial respiration in placenta with preeclampsia.

Authors:  S Muralimanoharan; A Maloyan; J Mele; C Guo; L G Myatt; L Myatt
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.